Old Web
English
Sign In
Acemap
>
authorDetail
>
Yukiko Tomochika
Yukiko Tomochika
Pfizer
Dermatology
Psoriasis
Tofacitinib
Janus kinase inhibitor
Adverse effect
2
Papers
68
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial
2017
Journal of Dermatology
Masatoshi Abe
Chikako Nishigori
Hideshi Torii
Hironobu Ihn
Kei Ito
Makoto Nagaoka
Naoki Isogawa
Isao Kawaguchi
Yukiko Tomochika
Mihoko Kobayashi
Anna M. Tallman
Kim Papp
Show All
Source
Cite
Save
Citations (15)
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study
2016
Journal of Dermatology
Akihiko Asahina
Takafumi Etoh
Atsuyuki Igarashi
Shinichi Imafuku
Hidehisa Saeki
Yoshiyuki Shibasaki
Yukiko Tomochika
Shigeyuki Toyoizumi
Makoto Nagaoka
Mamitaro Ohtsuki
Show All
Source
Cite
Save
Citations (53)
1
map